Clinically Relevant Genetic Insights in Hypothalamo-Pituitary Diseases, Amsterdam 2026

Event start 15/10/2026

Event end 17/10/2026

PARTICIPANT EVALUATION FORM

Your name

Optional

If you add your name, it is saved with your answers.

You can save this form and come back later. Saved answers stay available even if you do not submit. Choose Save progress, keep the code shown, and enter it here when you return.

If you saved your progress, enter your code

Clinically relevant genetic insights in hypothalamo-pituitary diseases 15-17 October 2026, Amsterdam

PLEASE FILL OUT THE FORM DURING THE COURSE – CME CERTIFICATES WILL BE EMAILED WITHIN 5-10 DAYS AFTER THE COURSE

(Please tick your choice)

What is your medical degree course?

How did you hear about this course?

Please tell us the reason why you chose this course.

(Please describe what you expect to get out of this course and why it is different from other available courses)

Do you have suggestions for new topics/future courses that you would like us to develop within rare diseases?

Would you be interested in proposing and organising a course within the next 2–3 years? If yes, please indicate the proposed topic and email ckellquist@rrd-foundation.org.

1) Quality of the event:

How useful for your professional activity did you find this event?

1Not useful2Fairly useful3Useful4Extremely useful

Overall, how do you rate this course?

1Very poor2Poor3Good4Excellent
PROGRAMME
ORGANISATION

What was the best aspect of the course?:

What was the worst aspect of the course?:

2) Relevance of the event:

Did the event fulfil your educational goals and expected learning outcomes?

1Not at all2Not much3Somewhat4Very much

Was the presented information well-balanced and consistently supported by a valid scientific evidence base?

1Not at all2Not much3Somewhat4Very much

If we were to organise this course again, for new delegates, what would you change?

How useful to you personally was each session?

Clinically relevant genetic insights in hypothalamo-pituitary diseases 15-17 October 2026, Amsterdam

1Not useful2Fairly useful3Useful4Extremely useful
Session 1: Genetic testing in the 21st century
Why do we need genetic testing in endocrinology?
The wonder of DNA and its assessment
Session 2: Genetic testing for guiding targeted treatment
Craniopharyngioma genetics
Targeted therapeutic options in craniopharyngiomas
Participants’ case presentations
Session 3: Specific genetic causes of pituitary hyperfunction
Familial isolated pituitary adenomas and AIP-related disease
X-linked acrogigantism
Multiple-endocrine Neoplasia type 1
Carney complex
Rare genotypes in pituitary diseases (MEN4, MEN5, SDH, Lynch, CHEK2)
Somatic variants and multiomics approaches in pituitary tumours
Debate: Shall we screen and follow up subjects in low penetrance disease or not?
What to do with the genetic results
Participants’ case presentations
Session 4: Workshops
Workshop 1: Practical session discussing family history, family tree, cascade testing, age ranges for testing.
Workshop 2: Practical session on gene panel assessment, testing criteria, advantages and disadvantages
Session 5: Kallmann syndrome and hypogonadotrophic hypogonadism
Participants’ Case presentations
Novel therapies arising from recent discoveries in the hypothalamo gonadal axis
Session 6: The patient’s voice in genetic diseases
Psychological aspects of genetic disease
The patient’s view: Living with genetic disease

4) Suitability of formats used during the event

Was there adequate time available for discussions questions & answers and learner engagement?

1Never2Only rarely3Sometimes4Always/almost always

Can you indicate any innovative elements during the activity?

5) Ways the event affects clinical practice:

Will the information you learned be implemented in your practice?

1Not at all2Not much3Somewhat4Very much

Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):

Or, can you provide ONE example how this event will influence your future practice?

Of the patients you will see in the next month, about how many will benefit from the information you learned today?

6) Commercial bias

Did all the faculty members provide their potential conflict of interest declaration with the sponsor(s) as a second slide of their presentation?

1No2Yes but only a small part3Yes, the majority4Yes, all

Can you provide an example of biased presentation in this activity?

Do you agree that the information was overall free of commercial and other bias?

Do you have any additional suggestions or comments?

Please write your comments clearly